Cite
European surveillance of immunoglobulin safety--results of initial survey of 1243 patients with primary immunodeficiencies in 16 countries.
MLA
Quinti, Isabella, et al. “European Surveillance of Immunoglobulin Safety--Results of Initial Survey of 1243 Patients with Primary Immunodeficiencies in 16 Countries.” Clinical Immunology (Orlando, Fla.), vol. 104, no. 3, Sept. 2002, pp. 231–36. EBSCOhost, https://doi.org/10.1006/clim.2002.5239.
APA
Quinti, I., Pierdominici, M., Marziali, M., Giovannetti, A., Donnanno, S., Chapel, H., Bjorkander, J., & Aiuti, F. (2002). European surveillance of immunoglobulin safety--results of initial survey of 1243 patients with primary immunodeficiencies in 16 countries. Clinical Immunology (Orlando, Fla.), 104(3), 231–236. https://doi.org/10.1006/clim.2002.5239
Chicago
Quinti, Isabella, Marina Pierdominici, Marco Marziali, Antonello Giovannetti, Simona Donnanno, Helen Chapel, Janne Bjorkander, and Fernando Aiuti. 2002. “European Surveillance of Immunoglobulin Safety--Results of Initial Survey of 1243 Patients with Primary Immunodeficiencies in 16 Countries.” Clinical Immunology (Orlando, Fla.) 104 (3): 231–36. doi:10.1006/clim.2002.5239.